Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-09-22

FDA Approved: RENOVA — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for RENOVA (tretinoin) submitted by Bausch Health US LLC, resulting in a labeling update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RENOVA (TRETINOIN)

Snippet

SUPPL AP for RENOVA (TRETINOIN)